Treatment of Pediatric Hypertension With Altace Trial
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
Ramipril is an ACE inhibitor that has been marketed in the US for the treatment of
hypertension since 1991. It has been shown to be effective in reducing both systolic and
diastolic blood pressure in adults when used once daily. ACE inhibitors are frequently used
to treat hypertension in children, however ramipril has not been extensively tested in
children, and information regarding the efficacy and safety would therefore be of benefit to
children. This study is designed to demonstrate the efficacy and safety of ramipril in the
treatment of hypertension in children ages 6 through 16 years.